Medicare Enrolled
Dr. Anant Sharma, M.D.
Student in an Organized Health Care Education/Training Program · Denton, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Sharma from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sharma? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Sharma
Dr. Anant Sharma is a student in an organized health care education/training program in Denton, TX, with 18 years in practice. Based on federal Medicare data, Dr. Sharma performed 93,345 Medicare services across 5,256 unique beneficiaries.
Between the years covered by Open Payments, Dr. Sharma received a total of $2,195 from 29 pharmaceutical and/or device companies across 58 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in student in an organized health care education/training program. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Sharma is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice▲ Top 0% volume in TX$ $2,195 industry payments
Medicare Practice Summary
Medicare Utilization ↗93,345
Medicare services
Top 0% in TX for student in an organized health care education/training program
5,256
Unique beneficiaries
$10
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~5,186 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) | 17,850 | $0 | $5 |
| Iron sucrose injection (Venofer) | 15,200 | $0 | $2 |
| Contrast dye for imaging (iodine-based) | 11,075 | $0 | $3 |
| Darbepoetin injection (Aranesp) for anemia | 10,315 | $2 | $20 |
| Pembrolizumab injection (Keytruda) | 10,200 | $43 | $137 |
| Anti-nausea injection (fosaprepitant) | 8,850 | $0 | $5 |
| Denosumab injection (Prolia/Xgeva) | 4,680 | $18 | $66 |
| Complete blood count (CBC) with differential | 1,611 | $8 | $36 |
| Blood draw (venipuncture) | 1,495 | $8 | $20 |
| Comprehensive metabolic blood panel | 1,458 | $10 | $64 |
| Dexamethasone injection (steroid) | 1,330 | $0 | $1 |
| Injection, granisetron hydrochloride, 100 mcg | 1,020 | $0 | $24 |
| Office visit, established patient (30-39 min) | 812 | $90 | $368 |
| Anti-nausea injection (Aloxi/palonosetron) | 790 | $1 | $114 |
| Injection, fluorouracil, 500 mg | 443 | $2 | $13 |
| Iron level test | 419 | $6 | $27 |
| Iron binding capacity test | 419 | $9 | $35 |
| Ferritin level test (iron stores) | 418 | $13 | $60 |
| Office visit, established patient (20-29 min) | 387 | $57 | $250 |
| Injection of additional new drug or substance into vein | 385 | $11 | $108 |
| Injection, magnesium sulfate, per 500 mg | 314 | $0 | $6 |
| Administration of chemotherapy into vein, 1 hour or less | 252 | $94 | $707 |
| Lactate dehydrogenase (enzyme) level | 244 | $6 | $31 |
| Injection, carboplatin, 50 mg | 224 | $2 | $300 |
| Drug injection, under skin or into muscle | 212 | $10 | $96 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 198 | $19 | $157 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 175 | $46 | $313 |
| Reticulated (young) platelet measurement | 160 | $35 | $143 |
| Microscopic examination for white blood cells with manual cell count | 143 | $4 | $22 |
| Complete blood count (CBC), automated | 143 | $6 | $34 |
| Ct scan of chest with contrast | 129 | $50 | $821 |
| Basic metabolic blood panel | 125 | $8 | $49 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 123 | $54 | $211 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 119 | $15 | $100 |
| Injection, diphenhydramine hcl, up to 50 mg | 112 | $1 | $7 |
| CT scan of abdomen and pelvis with contrast | 109 | $167 | $1,067 |
| Magnesium level test | 109 | $6 | $29 |
| Injection, zoledronic acid, 1 mg | 100 | $6 | $431 |
| New patient office visit (45-59 min) | 99 | $118 | $565 |
| Administration of chemotherapy into vein, each additional hour | 95 | $19 | $161 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 94 | $90 | $657 |
| Infusion, normal saline solution , 1000 cc | 91 | $2 | $19 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 84 | $1,096 | $4,802 |
| Administration of additional new drug or substance into vein, 1 hour or less | 81 | $48 | $344 |
| Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services | 67 | $70 | $70 |
| Hospital follow-up visit, moderate complexity | 52 | $60 | $247 |
| Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l | 43 | $124 | $500 |
| Injection of drug or substance into vein | 41 | $27 | $247 |
| Office visit, established patient, complex (40-54 min) | 40 | $128 | $496 |
| Uric acid level test | 39 | $4 | $25 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 31 | $1 | $19 |
| Administration of additional new drug or substance into vein using push technique | 30 | $42 | $289 |
| CT scan of chest, without contrast | 29 | $36 | $686 |
| Infusion into a vein for hydration, 31-60 minutes | 29 | $25 | $256 |
| Red blood count automated, with additional calculations | 28 | $5 | $26 |
| Infusion into a vein for hydration, each additional hour | 27 | $10 | $75 |
| Ct scan of abdomen and pelvis without contrast | 26 | $65 | $560 |
| New patient office visit, complex (60-74 min) | 24 | $163 | $709 |
| Blood creatinine level | 22 | $5 | $31 |
| Urea nitrogen level to assess kidney function, quantitative | 22 | $4 | $24 |
| Manual urinalysis test with examination using microscope, non-automated | 20 | $4 | $26 |
| Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion | 20 | $15 | $94 |
| Irrigation of implanted venous access drug delivery device | 20 | $17 | $114 |
| Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | 19 | $272 | $2,762 |
| Ct scan of soft tissue of neck with contrast | 12 | $68 | $658 |
| Initial hospital admission, moderate complexity | 12 | $100 | $470 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
19.9% high complexity
70.9% medium
9.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$2,195
Total received (2018-2024)
Avg $314/year across 7 years
Top 15% in TX for student in an organized health care education/training program
29
Companies
58
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,323 (60.3%)
Other
Charitable contributions, space rental, and other categories
$833 (38.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$39 (1.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$1,491
2023$77
2022$212
2021$177
2020$17
2019$116
2018$105
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$853
PUMA BIOTECHNOLOGY, INC.
$247
E.R. Squibb & Sons, L.L.C.
$135
Myriad Genetic Laboratories, Inc.
$118
Celgene Corporation
$96
Daiichi Sankyo Inc.
$79
Merck Sharp & Dohme Corporation
$69
Incyte Corporation
$61
Takeda Pharmaceuticals U.S.A., Inc.
$58
PFIZER INC.
$55
Tempus AI, Inc
$49
INTUITIVE SURGICAL, INC.
$37
Lilly USA, LLC
$35
Dendreon Pharmaceuticals LLC
$33
Eisai Inc.
$25
Janssen Biotech, Inc.
$25
Merck Sharp & Dohme LLC
$25
Bayer Healthcare Pharmaceuticals Inc.
$23
AstraZeneca Pharmaceuticals LP
$20
Kite Pharma, Inc.
$19
Boehringer Ingelheim Pharmaceuticals, Inc.
$18
GlaxoSmithKline, LLC.
$17
GENZYME CORPORATION
$16
ARRAY BIOPHARMA INC
$16
ADC Therapeutics America, Inc.
$15
ABBVIE INC.
$15
Agios Pharmaceuticals, Inc.
$13
PharmaEssentia USA Corporation
$12
Gilead Sciences, Inc.
$12
Top 3 companies account for 56.3% of total payments
Associated products mentioned in payments ›
BESREMI · CREON · DARZALEX · Da Vinci Surgical System · EMPLICITI · Enhertu · FRUZAQLA · GILOTRIF · IBRANCE · ICLUSIG · INLYTA · JAKAFI · JEVTANA · KEYTRUDA · KISQALI · LYNPARZA · Lenvima · MONJUVI · NERLYNX · ONUREG · OPDIVO · PLUVICTO · PROVENGE · Pomalyst · PreciseTumor · REBLOZYL · RETEVMO · Stivarga · VERZENIO · XALKORI · Yescarta · ZEJULA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (60%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $2 per 100 Medicare services performed
Geographic Context
Student in an Organized Health Care Education/Training Programs within 10 mi
391
Per 100K population
41.3
County median income
$108,185
Nearest hospital
TEXAS HEALTH PRESBYTERIAN HOSPITAL DENTON
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Sharma is a mixed practice specialist, with above-average Medicare volume (top 0% in TX), and high industry engagement (low-engagement, top 15%), with 18 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Sharma experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Sharma performed 17,850 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Sharma receive payments from pharmaceutical companies?
Yes. Dr. Sharma received a total of $2,195 from 29 companies across 58 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sharma's costs compare to other student in an organized health care education/training programs in Denton?
Dr. Sharma's average Medicare payment per service is $10. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sharma) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Student in an Organized Health Care Education/Training Programs in Denton
Browse student in an organized health care education/training programs in Denton ranked by procedure volume and transparency data.
Highest volume
Top Student in an Organized Health Care Education/Training Programs in TX
Student in an Organized Health Care Education/Training Programs ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Student in an Organized Health Care Education/Training Programs in TX
Which TX student in an organized health care education/training programs receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
PUMA BIOTECHNOLOGY, INC. Payments to Doctors
See all physicians who received payments from PUMA BIOTECHNOLOGY, INC..
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology